, and showed the efficacy of disinfectants for both these viruses [18] .
Vaccines for feline viruses including FHV, FCV and FPLV have been developed and commercialized in several countries [7, 14] . In Japan, neither the vaccine for FHV nor FCV has been licenced and commercialized, though one feline vaccine for FPLV is permitted.
The present study was carried out to assure the safety and efficacy of the tri-combinant vaccine for FHV, FCV and FPLV, using Japanese native cats and virus strains isolated in Japan.
The application to cats for experimental use was also discussed. (male) and 2.4 to 3, lkg (female) at the end of observation.
Discussion
The F-2 strain of FHV and the F-9 strain of FCV were selected and attenuated by Bittle and York [1] as the viral strains of choice for vaccine development. It has been indicated that these strains did not cause significant disease and retained their antigenicity when administered intramuscularly [2, 3, 4, 17] . Concerning the antigenic difference of FCV, the F-9 strain was found to be serologically related to all other strains tested [10] , and induced antibodies against many strains including highly virulent 255 strain [5, 9] . The f ormalin-inactivated feline panleukopenia vaccine serving as the diluent for lyophilized FHV and FCV was the same one already licenced and commercialized here in Japan. Thus, the present study assured the safety and efficacy of the vaccine for Japanese native cats and the viral strains isolated in Japan.
The maternal antibodies against FHV and FCV have been shown to be retained for 9 to 10 weeks after birth [18] . When the queens had high antibody titers against FPLV, the kittens kept their maternal antibody as long as 12 to 16 weeks [16] .
The maternal antibodies seemed to interfere with the efficacy of the vaccine in some cases presented here, even though the kittens were vaccinated initially at 9 to 12 weeks of age and revaccinated at 3 weeks interval.
The absence of maternal immunity must be confirmed to assure good antibody production in kittens.
Bittle and Rubic have reported that vaccinated cats had low titers against FHV at 1 year after vaccination were protected when challenge exposed [4] . The results of this study showed that SN antibody titer against FHV was lower and declined earlier than that against other viruses, but could protect against FHV challenge.
The protective immunity against FHV may be concerned not only with humoral antibody but also with local and cell-mediated response. Thus, vaccinated cats appeared to have sufficient protective immunities at least for 6 months against FHV challenge and 1 year against FCV and FPLV.
As for the viral shedding from vaccinated cats, it has been reported that vaccinal viruses were not shed to susceptible contact controls [17] .
So far as the vaccine is injected intramuscularly or subcutaneously, it will be not need to fear on the shedding of vaccinal virus.
Orr et al. [13, 15] 
